Loading...
  • platelets
  • The main blood components (red blood cells, white blood cells, and platelets) are separated from the plasma by a centrifugal process, and the extracted cells are re-combined with a plasma replacement such as sterilized albumin. (sclero.org)
  • chemotherapy
  • Other treatments, such as chemotherapy, are needed to reduce the production of the protein by the plasma cells. (macmillan.org.uk)
  • The number of plasma exchanges that you need will depend on the amount of protein in your blood, your symptoms and your response to other treatments such as chemotherapy. (macmillan.org.uk)
  • cytokines
  • The rationale behind the use of plasma exchange (PE) includes the removal of autoantibodies and other plasma constituents, such as cytokines, complement components, neutrophil extracellular traps, and microparticles, and the substitution of missing plasma factors. (ovid.com)
  • refractory
  • We describe the case of a 33-year-old woman having corticosteroid-refractory eosinophilic granulomatosis with polyangiitis (EGPA) who presented with abdominal pain and responded dramatically to plasma exchange. (hindawi.com)
  • substances
  • Plasma is the liquid portion of blood which helps carry blood cells and other substances throughout your body. (sclero.org)
  • The kinetics of PE efficiency have been extensively investigated and exchange between body compartments of substances to be removed is of considerable importance. (ovid.com)
  • symptoms
  • Participants will be tested for signs and symptoms of autonomic failure, and will be asked to complete questionnaires about various symptoms before the plasma exchange, 1 or 2 weeks afterward, and then monthly or bimonthly for up to 1 year. (clinicaltrials.gov)
  • Testing for symptoms of autonomic failure and autonomic function testing will occur about 1 month after the plasma exchange and monthly or bimonthly for up to 1 year. (clinicaltrials.gov)
  • Disorders
  • Plasma exchange helps because it removes factors in the plasma thought to play a role in these disorders," said guideline lead author Irene Cortese, MD, a neurologist with the National Institutes of Health in Bethesda, Md., and a member of the American Academy of Neurology. (healthcanal.com)